Clinical Trial Update: Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on stem cell transplantation with T-cell add-back for bone marrow malignancies, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Immunosuppression, Leukemia | Phase 2 | Status: COMPLETED